Trials / Completed
CompletedNCT02067260
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Spencer Forrest, Inc. · Industry
- Sex
- Male
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The overall purpose of this clinical investigation is to collect data to support a marketing application for over the counter use of the X5 HairLaser with an indication for hair growth. The goal of this protocol is to demonstrate that the intended users of the X5 HairLaser can safely and effectively perform self-use application by following written instructions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | X5 HairLaser | Treatment consists of three, 10-15 minute, at-home treatments per week (on nonconcurrent days) for 26 weeks. |
| DEVICE | X5 Hair Laser Sham Device | Treatment consists of three, 10-15 minute, at-home treatments per week (on nonconcurrent days) for 26 weeks. |
Timeline
- Primary completion
- 2010-04-01
- First posted
- 2014-02-20
- Last updated
- 2014-02-20
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02067260. Inclusion in this directory is not an endorsement.